Table 2.
Pre-intervention status in EVT CVST-VITT patients.
| EVT CVST-VITT (n = 18) | Missing, n (%) | |
|---|---|---|
| Last pre-intervention clinical status | 5 (28) | |
| GCS <9, n (%) | 4 (31) | |
| GCS 9–12, n (%) | 4 (31) | |
| GCS 13–15, n (%) | 5 (38) | |
| ICU admission prior to EVT, n (%) | 11 (73) | 3 (17) |
| Sedation/intubation prior to EVT, n (%) | 10 (67) | 3 (17) |
| Last pre-intervention imaging | ||
| Hemorrhagic lesion, n (%) a | 16 (89) | - |
| Intraparenchymal, n (%) | 12 (80) | 3 (17) |
| Subarachnoid, n (%) | 6 (46) | 3 (17) |
| Subdural, n (%) | 2 (13) | 3 (17) |
| Epidural, n (%) | 0 | 3 (17) |
| Cerebral edema, n (%) | 6 (40) | 3 (17) |
| Midline shift, n (%) | 7 (47) | 3 (17) |
| Transtentorial herniation, n (%) | 3 (20) | 3 (17) |
| Last lab values a | ||
| Platelet count (×103/μL), median (IQR) | 67 (30–84) | - |
| D-dimer (mg FEU/L), median (IQR) | 20 (7–69) | 2 (11) |
| Fibrinogen (g/L), median (IQR) | 2.2 (1.8–3.6) | 4 (22) |
CVST: cerebral venous sinus thrombosis; EVT: endovascular treatment; FEU: fibrinogen equivalent units; IQR: interquartile range; VITT: vaccine-induced immune thrombotic thrombocytopenia.
a
If not available carried forward from admission (n = 3 for hemorrhagic lesion, D-Dimer and fibrinogen, n = 5 for platelet count).